Abbas Khan
Cited by
Cited by
Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019
KS Ikuta, LR Swetschinski, GR Aguilar, F Sharara, T Mestrovic, AP Gray, ...
The Lancet 400 (10369), 2221-2248, 2022
Higher infectivity of the SARS‐CoV‐2 new variants is associated with K417N/T, E484K, and N501Y mutants: an insight from structural data
A Khan, T Zia, M Suleman, T Khan, SS Ali, AA Abbasi, A Mohammad, ...
Journal of cellular physiology 236 (10), 7045-7057, 2021
The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019
KB Tran, JJ Lang, K Compton, R Xu, AR Acheson, HJ Henrikson, ...
The Lancet 400 (10352), 563-591, 2022
Marine natural compounds as potents inhibitors against the main protease of SARS-CoV-2—a molecular dynamic study
MT Khan, A Ali, Q Wang, M Irfan, A Khan, MT Zeb, YJ Zhang, ...
Journal of Biomolecular Structure and Dynamics 39 (10), 3627-3637, 2021
Virtual screening-driven drug discovery of SARS-CoV2 enzyme inhibitors targeting viral attachment, replication, post-translational modification and host immunity evasion …
MTJ Quimque, KIR Notarte, RAT Fernandez, MAO Mendoza, RAD Liman, ...
Journal of Biomolecular Structure and Dynamics 39 (12), 4316-4333, 2021
Immunoinformatics approaches to explore Helicobacter Pylori proteome (Virulence Factors) to design B and T cell multi-epitope subunit vaccine
M Khan, S Khan, A Ali, H Akbar, AM Sayaf, A Khan, DQ Wei
Scientific reports 9 (1), 13321, 2019
Combined drug repurposing and virtual screening strategies with molecular dynamics simulation identified potent inhibitors for SARS-CoV-2 main protease (3CLpro)
A Khan, SS Ali, MT Khan, S Saleem, A Ali, M Suleman, Z Babar, A Shafiq, ...
Journal of Biomolecular Structure and Dynamics 39 (13), 4659-4670, 2021
Phylogenetic analysis and structural perspectives of RNA-dependent RNA-polymerase inhibition from SARs-CoV-2 with natural products
A Khan, M Khan, S Saleem, Z Babar, A Ali, AA Khan, Z Sardar, ...
Interdisciplinary Sciences: Computational Life Sciences 12, 335-348, 2020
In silico and in vitro evaluation of kaempferol as a potential inhibitor of the SARS‐CoV‐2 main protease (3CLpro)
A Khan, W Heng, Y Wang, J Qiu, X Wei, S Peng, S Saleem, M Khan, ...
Phytotherapy Research 35 (6), 2841, 2021
Structural insights into the mechanism of RNA recognition by the N-terminal RNA-binding domain of the SARS-CoV-2 nucleocapsid phosphoprotein
A Khan, MT Khan, S Saleem, M Junaid, A Ali, SS Ali, M Khan, DQ Wei
Computational and structural biotechnology journal 18, 2174-2184, 2020
Immunoinformatics and structural vaccinology driven prediction of multi-epitope vaccine against Mayaro virus and validation through in-silico expression
S Khan, A Khan, AU Rehman, I Ahmad, S Ullah, AA Khan, SS Ali, ...
Infection, Genetics and Evolution 73, 390-400, 2019
Computational identification, characterization and validation of potential antigenic peptide vaccines from hrHPVs E6 proteins using immunoinformatics and computational systems …
A Khan, M Junaid, AC Kaushik, A Ali, SS Ali, A Mehmood, DQ Wei
PloS one 13 (5), e0196484, 2018
Designing multi-epitope vaccine against Staphylococcus aureus by employing subtractive proteomics, reverse vaccinology and immuno-informatics approaches
MT ul Qamar, S Ahmad, I Fatima, F Ahmad, F Shahid, A Naz, SW Abbasi, ...
Computers in Biology and Medicine 132, 104389, 2021
Immunoinformatic and systems biology approaches to predict and validate peptide vaccines against Epstein–Barr virus (EBV)
A Ali, A Khan, AC Kaushik, Y Wang, SS Ali, M Junaid, S Saleem, ...
Scientific reports 9 (1), 720, 2019
Network pharmacology: exploring the resources and methodologies
J Muhammad, A Khan, A Ali, L Fang, W Yanjing, Q Xu, DQ Wei
Current topics in medicinal chemistry 18 (12), 949-964, 2018
Immunogenomics guided design of immunomodulatory multi-epitope subunit vaccine against the SARS-CoV-2 new variants, and its validation through in silico cloning and immune …
A Khan, S Khan, S Saleem, N Nizam-Uddin, A Mohammad, T Khan, ...
Computers in Biology and Medicine 133, 104420, 2021
The Omicron (B. 1.1. 529) variant of SARS-CoV-2 binds to the hACE2 receptor more strongly and escapes the antibody response: Insights from structural and simulation data
A Khan, H Waris, M Rafique, M Suleman, A Mohammad, SS Ali, T Khan, ...
International Journal of Biological Macromolecules 200, 438-448, 2022
SARS-CoV-2 new variants: Characteristic features and impact on the efficacy of different vaccines
A Khan, T Khan, S Ali, S Aftab, Y Wang, W Qiankun, M Khan, M Suleman, ...
Biomedicine & Pharmacotherapy 143, 112176, 2021
Structural and free energy landscape of novel mutations in ribosomal protein S1 (rpsA) associated with pyrazinamide resistance
MT Khan, A Khan, AU Rehman, Y Wang, K Akhtar, SI Malik, DQ Wei
Scientific reports 9 (1), 7482, 2019
The SARS-CoV-2 B. 1.618 variant slightly alters the spike RBD–ACE2 binding affinity and is an antibody escaping variant: a computational structural perspective
A Khan, J Gui, W Ahmad, I Haq, M Shahid, AA Khan, A Shah, A Khan, ...
RSC advances 11 (48), 30132-30147, 2021
The system can't perform the operation now. Try again later.
Articles 1–20